SCHEMBL9214731

SCHEMBL9214731

COc1ccc(-c2cc(Cl)on2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.59
RAB9A P51151 7/20 0.59
MAPT P10636 5/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
SMN1; SMN2 Q16637 7/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 4/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.50
HTT P42858 1/20 0.50
CYP1A2 P05177 1/20 0.50
KDM4E B2RXH2 2/20 0.48
HPGD P15428 1/20 0.48
CASP3 P42574 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
PTPN1 P18031 1/20 0.46
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9214757 0.81 NPC1 (0.54) NPC1RAB9AMAPTSMN1; SMN2TDP1
SCHEMBL9219309 0.81 MAPT (0.51) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL1181029 0.80 NPC1 (0.87) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL6352561 0.80 RAB9A (0.61) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL9212438 0.79 RAB9A (0.56) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL9213944 0.79 RAB9A (0.59) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL1144008 0.79 NPC1 (0.59) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL6352556 0.79 NPC1 (0.59) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL10583890 0.79 RAB9A (0.59) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2
SCHEMBL1221306 0.78 MAPT (0.66) NPC1RAB9AMAPTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0446010-B1 Imidazole derivatives and antiepileptics comprising said imidazole derivatives as effective ingredients MITSUI TOATSU CHEMICALS (JP) 1995-03-08 EP disclosed
US-5112841-A Anticonvulsants MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 US disclosed
EP-0446010-A1 Imidazole derivatives and antiepileptics comprising said imidazole derivatives as effective ingredients MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-09-11 EP disclosed